LYZZ Capital

LYZZ Capital

A venture capital firm in Shanghai that focuses on pharmaceutical, medical, diagnostic and medical service industries.

LYZZ Capital is a venture capital firm in Shanghai that focuses on pharmaceutical, medical, diagnostic and medical service industries. Founded 2015 in Shanghai, China, it invests in series A, series B and venture rounds. Its portfolio companies include Qpex Biopharma, Alpha Biopharma, NewMed Medical, Neurelis, and Chipscreen. As of March 2020, LYZZ Capital has made six investments. Their most recent investment was on October 22, 2018, when Qpex Biopharma raised $33M. Qpex Biopharma, Inc. is a provider of biotechnology services and is based in San Diego, California, United States. LYZZ Capital specializes in seed, early, and expansion stage venture investments.

Timeline

2015

Founded

Funded Companies

Company
Industry
Website
Location
Qpex Biopharma
1 Result
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Kevin Li Ph.D

Founding Managing Partner

Leo Lv

Executive

Yao Lu

General Counsel

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

Alpha Biopharma

Chipscreen

Neurelis

NewMed Medical

Qpex Biopharma

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.